Last reviewed · How we verify
NCT05191108: PMS and MSRP
Premenstrual Syndrome (PMS) and Mindfulness Stress Reduction Program (MSRP)
NA trial testing mindfulness stres reduction programe in Premenstrual Syndrome in 74 participants. Completed in 30 April 2022.
21 April 2022
Quick facts
| Lead sponsor | NURDİLAN SENER |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 74 |
| Start date | 21 February 2022 |
| Primary completion | 21 April 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- mindfulness stres reduction programe
Conditions studied
- Premenstrual Syndrome — all drugs for Premenstrual Syndrome →
Sponsor
NURDİLAN SENER
Who can join
Adults 17 to 30, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Premenstrual syndrome (PMS) is a disorder characterized by emotional, physical and behavioral symptoms that increase the severity of the menstrual cycle in women of reproductive age during the luteal phase and disappear spontaneously a few days after the onset of menstruation. Nonpharmacological applications are often preferred to reduce premenstrual symptoms. It has been stated that with the meditation practices of mindfulness, individuals experience less anxiety, depression, anger and lower levels of psychological distress, including anxiety. . It is thought that the mindfulness stress reduction program can reduce the symptoms of PMS by regulating the stress level and emotional balance of women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effect of a Mindfulness-Based Stress Reduction Program on Premenstrual Symptoms: A Randomized Controlled Trial.
Şener Çetin N, Şolt Kırca A. · · 2023 · cited 5× · PMID 37335817 · DOI 10.1111/jmwh.13530
Verify or expand the search:
- PubMed search for NCT05191108
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premenstrual Syndrome
Currently open trials in the same condition.
- NCT07202650 — THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME · NA · recruiting
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT06771583 — Identification and Validation of Epigenetic Biomarkers of PMDD · recruiting
Other NURDİLAN SENER trials
Trials by the same sponsor.
- NCT05202054 — Insomnia and Mindfulness Stress Reduction Program · NA · completed
- NCT04762095 — The Effect of Mindfulness Stress Reduction Program on Menopausal Complaints and Quality of Life · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05191108 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NURDİLAN SENER
- Last refreshed: 9 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05191108.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing